Toho : Notice Regarding Launch of 3 Ingredients / 8 Products of Generic Drugs for KYOSOMIRAI PHARMA(162 KB)
June 14, 2024 at 03:23 am
Share
June 14, 2024
To whom it may concern:
Company Name
TOHO HOLDINGS CO., LTD.
Corporate
Atsushi Udoh, Representative Director,
Representative
CEO
(Prime Market of Tokyo Stock
Exchange Securities Code: 8129)
Contact:
Makoto Kawamura, Corporate Officer
and General Manager, Corporate
Strategy Division
(TEL: 81-3-6838-2803)
Notice Regarding Launch of
3 Ingredients / 8 Products of Generic Drugs for KYOSOMIRAI PHARMA
TOHO HOLDINGS CO., LTD. (Headquarters: Tokyo; Representative Director, CEO: Atsushi Udoh) is pleased to announce that KYOSOMIRAI PHARMA CO., LTD. (Headquarters: Tokyo; President and Representative Director: Yasuyuki Kumada), the wholly-owned subsidiary involved in pharmaceuticals manufacture and sales business, has launched 3 ingredients / 8 products of generic drugs today on June 14, 2024 as below.
New products list
Classes
Product Name
Original Brand Name
Therapeutic agent for
EPINASTINE HYDROCHLORIDE
Alesion Tablets
allergic disease
TABLETS 10mg /20mg "DAITO"
10 / 20
OLOPATADINE HYDROCHLORIDE
ALLELOCK Tablets
Therapeutic agent for
TABLETS 2.5mg/5mg "DAITO"
2.5 / 5
allergic disease
OLOPATADINE HYDROCHLORIDE OD
ALLELOCK OD
TABLETS 2.5mg/5mg "DAITO"
Tablets 2.5 / 5
Parkinson's disease drug
TRERIEF OD Tablets
Parkinsonism in dementia
Zonisamide OD Tablets 25mg TRE
with Lewy bodies
"DAITO"
25mg
(levodopa activator)
Parkinson's disease drug
Zonisamide OD Tablets 50mg TRE
TRERIEF OD Tablets
(levodopa activator)
"DAITO"
50mg
Attachments
Original Link
Original Document
Permalink
Disclaimer
Toho Holdings Co. Ltd. published this content on
14 June 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
14 June 2024 02:22:07 UTC.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
TOHO HOLDINGS CO., LTD. 
